Optimizing pharmacogenomic decision-making by data science.
Healthcare systems have made rapid progress towards combining data science with precision medicine, particularly in pharmacogenomics. With the lack of predictability in medication effectiveness from patient to patient, acquiring the specifics of their genotype would be highly advantageous for patien...
Main Authors: | Amir M Behdani, Jessica Lai, Christina Kim, Lama Basalelah, Trey Halsey, Krista L Donohoe, Dayanjan Wijesinghe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-02-01
|
Series: | PLOS Digital Health |
Online Access: | https://journals.plos.org/digitalhealth/article/file?id=10.1371/journal.pdig.0000451&type=printable |
Similar Items
-
Optimizing pharmacogenomic decision-making by data science
by: Amir M. Behdani, et al.
Published: (2024-02-01) -
Clinical implementation of RNA signatures for pharmacogenomic decision-making
by: Tang W, et al.
Published: (2011-09-01) -
494 Expert group decision making for pharmacogenomic testing in Ontario
by: Samuel Neumark, et al.
Published: (2024-04-01) -
Human pharmacogenomics: The development of a science
by: Kalow Werner
Published: (2004-08-01) -
An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
by: Jose Antonio Miñarro-Giménez, et al.
Published: (2014-01-01)